Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9,295 | 17,049 | 19,360 | 27,728 | 45,115 | 52,283 | 58,836 | 56,157 |
| EBITDA | 9 | 1,397 | 3,459 | 3,172 | 5,681 | 4,998 | 5,506 | 3,943 |
| Net profit | 6 | 1,108 | 1,735 | 1,158 | 2,817 | 2,777 | 2,843 | 1,675 |
| Total assets | 8,538 | 15,893 | 19,423 | 23,533 | 37,707 | 38,743 | 48,567 | 35,241 |
| n (companies reporting) | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Endokrinologiis Erovnul… | 0 | 4,131 | 4,782 | 5,454 | 8,331 | 9,911 | 14,193 | 15,944 |
| Curatio | 9,295 | 9,031 | 9,283 | 8,676 | 11,234 | 12,819 | 13,274 | 14,553 |
| Med Investment | — | — | 0 | 5,091 | 9,246 | 11,360 | 11,967 | 14,149 |
| Reimani | — | — | 0 | 1,141 | 6,049 | 6,619 | 7,773 | 11,511 |
| Adiktologiis Regionalur… | 0 | 3,888 | 5,296 | 7,367 | 10,254 | 11,574 | 11,629 | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2017–FY2019, FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.